Basivertebral Nerve Ablation (Intracept) for Chronic Vertebrogenic Low Back Pain in Hoffman Estates, IL
I see this in my practice every week. A patient walks in with chronic low back pain — sometimes a decade of it — and a stack of MRIs, prior injections, a course of physical therapy, and a deepening sense that nobody has been able to explain why their back hurts. Then I look at the imaging, see the Modic Type 1 or 2 endplate changes on the vertebral bodies, and the whole picture clicks. Their pain is coming from inside the bone itself — specifically from a small nerve called the basivertebral nerve — and there is a one-time outpatient procedure designed to address exactly that. That procedure is basivertebral nerve ablation, commercially called Intracept, made by Relievant Medsystems.
This page walks through what it is, who is actually a candidate (the indications are very specific), what the evidence shows, and how I decide between this and the other procedures in my toolkit.
What basivertebral nerve ablation is
Inside each vertebral body runs a small sensory nerve called the basivertebral nerve. It carries pain signals from the endplates — the flat surfaces at the top and bottom of each vertebra where the disc sits. When endplates become inflamed and damaged over years of degenerative wear, that nerve becomes a persistent pain generator. Conventional treatments aimed at discs, joints, and muscles don’t reach it because the nerve is buried inside the bone.
The Intracept procedure addresses that nerve directly. Through a small portal in the back, under fluoroscopic (live X-ray) guidance, I advance a cannula into the targeted vertebral body, deploy a curved probe to the precise location of the basivertebral nerve, and use radiofrequency energy to ablate it. The bone heals over the access tract. The nerve does not regenerate in any clinically meaningful way. One treatment. Not repeated. That single-procedure durability is the defining feature of this technology.
Who is a candidate?
This is the part of the conversation I am the most careful about, because the indication for Intracept is narrower than most patients arrive expecting.
You are a candidate if all of the following are true:
- Chronic low back pain ≥6 months that has not responded adequately to at least 6 months of conservative care.
- Pain is axial and vertebrogenic in pattern — meaning it’s centered in the low back, worsened by activities that load the spine (sitting upright for long periods, standing, bending forward), and often described as a deep ache rather than a sharp or radiating pain.
- MRI shows Modic Type 1 or Type 2 endplate changes at one or more lumbar levels — typically L3-L4, L4-L5, or L5-S1. These are specific signal changes on T1 and T2 sequences that indicate inflammation and fatty replacement at the vertebral endplates. Without Modic changes, the indication for Intracept is weak. Full stop.
If your pain is primarily radicular (shooting down the leg), if your imaging shows facet arthropathy as the dominant finding, if your stenosis is what’s limiting you, or if your MRI doesn’t show Modic changes — this is not your procedure. I have turned away patients who came in specifically asking for Intracept because their MRI didn’t support the diagnosis. I won’t perform a procedure that doesn’t match the anatomy.
A few additional factors I weigh: prior response to medial branch blocks (a positive medial branch response shifts the diagnosis toward facet-mediated pain, which points toward RFA rather than Intracept), surgical history at the targeted levels, and patient activity goals. Many of my Intracept candidates are otherwise healthy adults in their 40s, 50s, and 60s who have lost the ability to do the things that define them — and who don’t fit the spine-surgery profile.
What fails before this procedure
Intracept is not a first move. By the time a patient gets to my procedure schedule, we have almost always already tried:
- Conservative care — at least 6 months of physical therapy, oral medications, activity modification, and lifestyle measures.
- Targeted injections — usually epidural steroid injections, sometimes facet injections or medial branch blocks. Many of these patients have partial, short-lived, or no response from injections, which is itself an informative finding.
- Adjacent diagnoses ruled out — when I see a patient with chronic axial back pain, I am not just looking for Modic changes. I am ruling out facet-mediated pain (medial branch block diagnostic), SI joint pain (diagnostic SI block), and discogenic pain that is not endplate-driven. The differential matters because the procedures don’t overlap.
When conservative care, injections, and a careful diagnostic workup all converge on vertebrogenic pain with Modic changes, Intracept becomes the right conversation. The framing I use with patients: this is a one-time procedure for a specific anatomic problem, with the best durability data in interventional spine.
What the procedure looks like
Day-of-procedure starts with the same logistics as my other spine interventions. You’ll arrive at the procedure suite a couple of hours before your scheduled time. We confirm medications, manage any blood-thinner holds coordinated with your prescriber, place an IV, and review consent in person. No food or drink after midnight.
You’ll lie face-down on the fluoroscopy table. I typically use IV moderate sedation — twilight, not general anesthesia — combined with generous local anesthetic at the access points. Most patients are sleepy but responsive. We confirm the target vertebral bodies on live X-ray, mark the access points on your skin, and inject local anesthetic.
Through a small portal, I introduce the working cannula into the pedicle of the targeted vertebra and advance it into the vertebral body under fluoroscopic guidance. Once we’re in the correct position, the Intracept probe is deployed — it has a curved tip designed to reach the central location of the basivertebral nerve — and the radiofrequency generator is activated. The ablation itself takes about 15 minutes per level. We typically treat two or three levels in a single session (commonly L4 and L5, sometimes L3, L4, and L5). Total procedure time, access to closure, is usually 60 to 90 minutes.
Closure is a small adhesive strip per access point. You’ll be observed in recovery for an hour or two, walked to confirm you’re mobilizing safely, and discharged home the same afternoon with a responsible driver. Same-day discharge is standard.
Recovery and what to expect
The first 24 hours are usually the most cautious — soreness at the access sites, sometimes a deep ache as the local anesthetic wears off. I want you walking, but no lifting over 10 pounds, no driving until the next day, no heavy bending or twisting.
Most patients are back to light activity within 1 to 2 weeks. Desk work usually resumes within a few days. The honest framing on the timeline: this is a slower-onset procedure than something like an epidural injection. The maximum benefit develops over 6 weeks to 3 months as the inflammation in the treated bone settles down. Some patients feel meaningful improvement within the first month; others continue to improve out to the 3-month mark. I ask my patients to be patient with the curve.
For my more athletic patients — and yes, the irony isn’t lost on me as a triathlete — we hold off on running, heavy lifting, and impact sports for about 4 weeks, then ramp structured training back in gradually. By 3 months the result is what it’s going to be, and that’s when we measure success not just in pain scores but in functional capacity: how long you can sit, stand, lift, and engage with the activities that matter to you.
Risks
The Intracept procedure has a strong safety profile, but I am honest about risk in every consent conversation. Common, expected, and self-limited: access-site soreness, temporary increase in back pain for a few days as the treated area settles, mild bruising. Uncommon but possible: persistent pain at the access tract, no improvement in symptoms, small bleeding from the access. Rare but serious: vertebral fracture at the treated level (vanishingly rare in the published evidence), infection requiring antibiotics, and — extremely rare — injury to surrounding structures. The SMART trial reported a very low rate of device- or procedure-related serious adverse events through five years of follow-up, which gives me confidence offering this procedure as a durable solution rather than a stopgap.
Alternatives and how I decide
This is the conversation patients want most, because the menu of spine procedures has gotten genuinely confusing.
Intracept versus radiofrequency ablation (RFA) of the medial branches. These two procedures treat completely different pain generators. RFA targets the small nerves that supply the facet joints — the joints at the back of the spine that allow movement. Intracept targets the basivertebral nerve inside the vertebral body. The diagnostic gate is different: RFA candidates have a positive medial branch block response; Intracept candidates have Modic changes on MRI. Sometimes I do both, sequentially, when a patient has both pain generators. The durability is different too — RFA typically needs to be repeated every 9 to 18 months as the medial branch nerves regrow, while Intracept is designed as a one-time procedure. See my radiofrequency ablation page for the RFA-specific deep dive.
Intracept versus MILD. Different problems entirely. MILD decompresses a thickened ligamentum flavum in patients with spinal stenosis and neurogenic claudication — leg-dominant symptoms with walking. Intracept treats axial vertebrogenic back pain with Modic changes. Sometimes patients have both stenosis and Modic-pattern back pain, and we sequence the procedures carefully based on which is causing the most disability.
Intracept versus epidural steroid injections. Epidurals are useful for radicular pain and for some inflammatory components of axial pain, but they are not a long-term solution and they don’t address vertebrogenic pain specifically. When a patient’s epidurals are giving them weeks of relief instead of months, and the MRI shows Modic changes, that’s the signal to consider Intracept.
Intracept versus fusion surgery. This is where the value proposition is clearest. For the right Intracept candidate — Modic-pattern vertebrogenic pain — a one-time outpatient ablation can deliver durable relief without the morbidity, hardware, recovery, or adjacent-segment-disease risk of a lumbar fusion. I do not present Intracept as a fusion replacement in all back-pain patients; I present it as the right tool when the diagnosis fits.
Evidence I rely on. The SMART trial 5-year results (Fischgrund et al., Pain Practice, 2020, PMID 32616502) demonstrated durable pain and function improvement out to five years in patients treated with basivertebral nerve ablation — a remarkable durability profile for an interventional procedure. The Khalil et al. INTRACEPT randomized controlled trial (Spine Journal, 2019, PMID 31254985) showed superiority over standard care at 3 and 12 months. Together these studies underpin the indication and the insurance coverage.
Insurance
Intracept is covered by Medicare under a National Coverage Determination when the indications are met — chronic low back pain ≥6 months, conservative care failure, and MRI evidence of Type 1 or Type 2 Modic changes at the targeted levels. Many commercial insurers cover it as well, often with prior authorization. My office handles the prior auth documentation, and what helps the approval most is a clean MRI report that specifically identifies Modic changes by type and level. Many radiology reports describe endplate changes in generic terms — if your imaging is from another facility, you may need an addendum or a re-read specifically calling out Modic classification. We help with that.
FAQ
How is Intracept different from regular radiofrequency ablation?
RFA treats the medial branch nerves outside the spine that supply the facet joints. Intracept treats the basivertebral nerve inside the vertebral body. Different nerves, different pain patterns, different indications. RFA is usually repeated every 9 to 18 months; Intracept is one time.
Will I feel the ablation?
Under IV moderate sedation, most patients don’t feel the ablation itself. You may feel pressure or warmth. Local anesthetic is generous at the access points. Patients describe the experience as more comfortable than they expected.
How long until I know if it worked?
The maximum benefit develops over 6 weeks to 3 months. Some patients feel meaningful improvement within the first month, but I tell everyone to expect a gradual curve rather than an overnight change. At 3 months we measure the result.
Can the basivertebral nerve grow back?
Not in any clinically meaningful way. That’s why Intracept is positioned as a one-time procedure with durable results. The five-year SMART trial data supports that durability.
What if Intracept doesn’t work for me?
You still have every option you had before. The procedure does not preclude future epidural injections, RFA at the facets if a different pain generator emerges, or surgical consultation if the picture changes. The honest version: about 70% of well-selected SMART trial patients had meaningful improvement at 5 years, and the remainder kept their full set of alternatives.
Do I need to stop my blood thinner?
Usually yes, with hold instructions coordinated with your prescribing physician. The procedure cannot be done on full anticoagulation. We help with that coordination.
If you’re considering Intracept
If you have years of axial low back pain, your MRI mentions Modic changes, and you’ve worked through conservative care and injections without lasting relief — it is worth getting a careful evaluation before you commit to fusion or accept the diagnosis of “chronic, manage it forever.” I review every Intracept candidate personally, look at the actual imaging, and tell you honestly whether the procedure fits your anatomy. Call my Hoffman Estates office at (847) 981-3630 to schedule a consultation.